Tag Archives: Drug Enforcement Agency

Survey: 11% of Government Employees in D.C. Area Have Bought Legal Pot

Survey: 11% of Government Employees in D.C. Area Have Bought Legal Pot

Survey: 11% of Government Employees in D.C. Area Have Bought Legal Pot

Washington, D.C., isn’t a large market for the cannabis industry, but it could be very influential with regards to legalization. It turns out that quite a few cannabis buyers are government employees, according to new research.

Investors Are Betting Big Against Marijuana Stock Insys Therapeutics

Investors Are Betting Big Against Marijuana Stock Insys Therapeutics

As of April 13, 2017, more than 10.4 million shares of Insys Therapeutics (NASDAQ: INSY) were sold short. That’s 44% of the marijuana stock’s float. Investors have clearly bet big against Insys, anticipating that the stock will sink.

Maridose

First Medical Marijuana Dosage Calculator Launched on the Apple App Store

BOCA RATON, Fla., May 7, 2017 /Weed Wire/ – Maridose LLC, the Florida based company founded by former Procter & Gamble executive and advertising consultant, announced today that its’ new Maridose Marijuana Dosage Calculator is now available on the Apple APP store.

Federal Marijuana Does Not Test Well

Federal Marijuana Does Not Test Well

Marijuana grown by the federal government for research purposes does not have the same quality as the pot from other sources. Until recently, the U.S. federal government had to grow all the marijuana that would be used in scientific research, but researchers have found the government’s pot to be, essentially, irrelevant.

As Sessions Hearings Begin, Rumors About Shuttering Dispensaries Circulate

As Sessions Hearings Begin, Rumors About Shuttering Dispensaries Circulate

As U.S. Senate hearings began on Jan. 10, 2017, for Sen. Jeff Sessions, President-elect Donald Trump’s anti-marijuana nominee for Attorney General, rumors about the Drug Enforcement Agency shutting down dispensaries were already circulating.

DEA funds

DEA Funds For Uprooting Pot Plants Wasted in New Hampshire And Utah

In some states, DEA funds for destroying marijuana plants have not amounted to money well spent, according to The Washington Post’s Wonkblog. Last year, the DEA sent $20,000 to New Hampshire for a plant eradication program, but state law enforcement agencies found one growth site with 27 plants.

American Legion

American Legion Urges The DEA to Support Medical Marijuana

The American Legion, an organization of 2 million U.S. military veterans, recently passed a resolution calling on the Drug Enforcement Agency to support medical marijuana. The resolution was passed during the American Legion’s National Convention, which ran Aug. 30-Sept. 1, 2016, in Cincinatti, Ohio.

Americans for Safe Access Opioid Veterans Senate Committee

Patient Advocacy Group Releases Comparative Analysis of DEA Marijuana Scheduling Decision

WASHINGTON, Sept. 1, 2016 /Weed Wire/ — Today, Americans for Safe Access (ASA) disseminated a report comparing the body of research the Drug Enforcement Administration (DEA) used as a basis for their decision to keep cannabis (marijuana) as a Schedule I substance.

Cole Memo

Gov. Inslee Statement on DEA’s Marijuana Decision

OLYMPIA, Wash., Aug. 11, 2016 /Weed Wire/ — Gov. Jay Inslee issued a statement today on the Drug Enforcement Agency’s decision today not to reschedule marijuana in its listing of illegal substances under the federal Controlled Substances Act.

DEA Petition

Marijuana Supporters Call For DEA Chief’s Removal

Medical marijuana supporters are calling for the resignation of DEA Chief Chuck Rosenberg. According to the The Washington Post, Rosenberg called medical marijuana “a joke” and doubted its efficacy as a medicine during a Q&A session with reporters on Nov. 4, 2015.

bladder

Marijuana May Lower Risk of Bladder Cancer in Men

A study released in the Journal of Urology has found that marijuana use may lead to decreased risks of bladder cancer in men. Led by Dr. Anil A. Thomas, researchers examined medical data from the California Men’s Health Study cohort, evaluating 84,170 participants between the ages of 45 and 69.


Top